We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
New February results on Import and Export Prices have hit the tape this morning, with both headline numbers hotter than expected: Imports reached +0.6% from the +0.4% estimated, and Exports also hit +0.6% from -0.1% anticipated.
These numbers depict energy-driven growth, as we see when we strip out petroleum imports and wind up with a +0.1% figure. Year over year, Imports registered -1.3% on the headline, a smaller negative than in the previous read. Exports of energy helped today’s headline number swing from a negative estimate, and year over year Exports are +0.3%.
Initial Jobless Claims crept higher week over week, by 6000 claims to be exact from the previous week, to 229K overall. This is technically above our long-term range of 200-225K we’d enjoyed for most of the past year-plus, but still consistent with our healthy domestic labor market. We have surrendered our 50-year lows we’d been experiencing late last summer, but it’s nothing worth losing any sleep over.
Continuing Claims also bumped up a bit, to 1.776 million longer-term jobless claims from 1.758 million the previous week. Again, these remain consistent with a favorable employment situation, which for February reported Unemployment at a mere 3.8%. That said, we do see things cooling a bit on this front, and we will continue to monitor where these weekly claims figures keep increasing.
Dollar General (DG - Free Report) reported fiscal Q4 earnings results before the bell this morning, with mixed results: earnings of $1.84 per share missed the Zacks consensus by 4 cents, even as the bottom line grew 24% year over year. Revenues in the quarter of $6.65 billion outperformed estimates by 0.72%. Shares are trading down 7% in today’s pre-market, after having climbed nearly 12% year to date. For more on DG’s earnings, click here.
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
Imports/Exports Heat Up, Jobless Claims Increase
Thursday, March 14, 2019
New February results on Import and Export Prices have hit the tape this morning, with both headline numbers hotter than expected: Imports reached +0.6% from the +0.4% estimated, and Exports also hit +0.6% from -0.1% anticipated.
These numbers depict energy-driven growth, as we see when we strip out petroleum imports and wind up with a +0.1% figure. Year over year, Imports registered -1.3% on the headline, a smaller negative than in the previous read. Exports of energy helped today’s headline number swing from a negative estimate, and year over year Exports are +0.3%.
Initial Jobless Claims crept higher week over week, by 6000 claims to be exact from the previous week, to 229K overall. This is technically above our long-term range of 200-225K we’d enjoyed for most of the past year-plus, but still consistent with our healthy domestic labor market. We have surrendered our 50-year lows we’d been experiencing late last summer, but it’s nothing worth losing any sleep over.
Continuing Claims also bumped up a bit, to 1.776 million longer-term jobless claims from 1.758 million the previous week. Again, these remain consistent with a favorable employment situation, which for February reported Unemployment at a mere 3.8%. That said, we do see things cooling a bit on this front, and we will continue to monitor where these weekly claims figures keep increasing.
Dollar General (DG - Free Report) reported fiscal Q4 earnings results before the bell this morning, with mixed results: earnings of $1.84 per share missed the Zacks consensus by 4 cents, even as the bottom line grew 24% year over year. Revenues in the quarter of $6.65 billion outperformed estimates by 0.72%. Shares are trading down 7% in today’s pre-market, after having climbed nearly 12% year to date. For more on DG’s earnings, click here.
After today’s close, we see a surprising number of earnings results set to come out, including tech majors Oracle (ORCL - Free Report) , Adobe (ADBE - Free Report) and Broadcom (AVGO - Free Report) , as well as specialty retailers Ulta (ULTA - Free Report) , Zumiez (ZUMZ - Free Report) , Tilly’s (TLYS - Free Report) and Turtle Beach (HEAR - Free Report) .
Mark Vickery
Senior Editor
Questions or comments about this article and/or its author? Click here>>
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
See Stocks Today >>